Standard BioTools与SomaLogic合并后将以Treeline Biosciences运营,预计2026年下半年完成并以“Trln”代码交易

美股速递
Jun 08

Standard BioTools Inc. 与SomaLogic的合并计划已取得关键进展。根据最新公告,合并后的实体将正式以Treeline Biosciences的名称运营,并预计在2026年下半年交易完成之后,在纳斯达克以股票代码“Trln”进行交易。

此次合并旨在整合双方在生命科学工具和蛋白质组学分析领域的优势,打造一个更具竞争力的平台。新名称Treeline Biosciences象征着对科学探索前沿的追求,而新交易代码“Trln”则提供了简洁的市场标识。公司表示,此举是合并进程中的重要里程碑,将为股东和客户创造长期价值。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10